Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 76204-600

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 76204-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ipra-alb 30 Ct Brick Carton (Rpsc0200 Rdp Ipra Alb 30 Ct Brick Carton Pdf Proof)

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg / 3 mg per 3 mL by Ritedose Pharmaceuticals, LLC. The label indicates it is a prescription human drug supplied in sterile unit-dose vials (30 vials per pouch) intended for oral inhalation only. The label includes product information, ingredients, NDC 76204-600-30, usage instructions, and barcodes.*

FDA Label Image

60 Ct Brick Carton (Rpsc0201 60 Ct Brick Carton)

Packaging label for Ipratropium Bromide and Albuterol Sulfate inhalation solution 0.5 mg/3 mg per 3 mL by Ritedose Pharmaceuticals, LLC. The label indicates it is a respiratory solution for oral inhalation in 60 sterile unit-dose vials (2 pouches of 30 x 3 mL vials). The design includes purple and blue horizontal stripes with the product name and strength prominently displayed.*

FDA Label Image

Ipra-alb 30 Ct Cards Carton (Rpsc0265 Rdp Ipra Alb 30 Ct Cards Carton Pdf Proof New)

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg / 3 mg per 3 mL. The label indicates it is a human prescription drug in solution dosage form for respiratory inhalation. The labeler is Ritedose Pharmaceuticals, LLC. The label includes NDC 76204-600-05 and specifies the product is for oral inhalation only, provided in 30 vials of 3 mL each.*

FDA Label Image

Rdp Ipra-alb 60 Ct Cards Carton (Rpsc0266 Rdp Ipra Alb 60 Ct Cards Carton Pdf Proof New)

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg / 3 mg per 3 mL by Ritedose Pharmaceuticals, LLC. The label indicates the product is for oral inhalation only and available as 60 sterile unit-dose vials (12 pouches of 5 vials each). The design uses a blue and purple color scheme with text and barcodes visible.*

FDA Label Image

Rdp Ipra-alb 30 Ct Singles Carton (Rpsc0301 Rdp Ipra Alb 30 Ct Singles Carton With New Design Pdf Proof)

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, 0.5 mg / 3 mg per 3 mL, by Ritedose Pharmaceuticals, LLC. The label includes dosage form and strength, NDC 76204-600-01, barcodes, and usage information for oral inhalation. The box design features purple highlights and a depiction of a single-dose vial.*

FDA Label Image

Chemical Structure (Ipratropium 01)

Chemical structure of Ipratropium Bromide and Albuterol Sulfate depicted as a molecular diagram showing the arrangement of atoms and bonds for the active ingredients.*

FDA Label Image

Chemical Structure (Ipratropium 02)

Chemical structure of Ipratropium Bromide, showing its molecular arrangement including a bicyclic ring, ester linkage, quaternary ammonium, and bromide hydrate moiety.*

FDA Label Image

Figure (Ipratropium 03)

A line graph showing volume in liters (y-axis) over hours after dosing (x-axis) up to 8 hours. It compares the respiratory volume changes over time for Albuterol alone, Ipratropium alone, and the combination of Ipratropium Bromide and Albuterol Sulfate, with distinct line styles and markers for each.*

FDA Label Image

Figure 1 (Ipratropium 04)

An instructional diagram illustrating the use of a respiratory inhalation device. It shows a hand holding a small vial or ampule and positioning it to fill or connect with an inhaler mouthpiece or chamber, labeled as Figure 1.*

FDA Label Image

Figure 2 (Ipratropium 05)

An instructional diagram showing a hand holding the mouthpiece of a respiratory inhalation device and another hand preparing to insert a small vial or ampule into the device. This figure likely illustrates a step in assembling or preparing the inhalation solution for use.*

FDA Label Image

Figures 3 And 4 (Ipratropium 06)

Illustrations showing proper use of a respiratory inhalation device for Ipratropium Bromide and Albuterol Sulfate inhalation solution. Figure 3 depicts a person placing the device mouthpiece directly into the mouth, while Figure 4 shows using a spacer or holding chamber attached to the device during inhalation.*

FDA Label Image

Rdp Logo (Ipratropium 07)

The image shows a Ritedose Pharmaceuticals, LLC branded medication label for Ipratropium Bromide and Albuterol Sulfate solution for respiratory inhalation. The label highlights the combined active ingredients, indicates the product is a human prescription drug, and includes dosage forms with strengths of 2.5 mg and 0.5 mg per 3 mL. The label features the Ritedose Pharmaceuticals logo prominently at the top.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.